Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 13, 2026
Hudson Technologies (HDSN): Is the Path to $8 and a +48% Gain Still Viable?

Hudson Technologies (HDSN): Is the Path to $8 and a +48% Gain Still Viable?

Key Takeaways

  • The stock of Hudson Technologies, Inc. (HDSN), a U.S. refrigerant reclamation and services company, last closed near $5.41, making an $8 target a rise of roughly 48%.
  • The strongest bullish case rests on regulatory tailwinds from the American Innovation and Manufacturing (AIM) Act, a $210 million Defense Logistics Agency contract, and Hudson's position as one of the largest U.S. refrigerant reclaimers.
  • The biggest obstacles are compressed gross margins, weak refrigerant spot prices, and downward revisions to analyst price targets.
  • Key technical levels include support near $4.64–$5.00 and resistance around $6.00, with $8 acting as the next major upside objective.
  • Analyst targets cluster between $7.00 and $9.50, suggesting $8 is a plausible but not guaranteed medium-term milestone.

Why the $8 Level Continues to Draw Attention

Investors following Hudson Technologies have been weighing whether the stock can return to the $8 mark. That level aligns with several published analyst price targets and carries psychological weight for a name that has dropped from its 52-week high of $10.52. Trading near $5.41 today, a move to $8 would deliver the kind of upside that remains consistent with existing Wall Street forecasts.

Business Overview and Market Standing

Hudson Technologies supplies refrigerant and industrial gas sales, reclamation, and management services for commercial air conditioning, industrial processing, and refrigeration systems. As one of the largest refrigerant reclaimers in the United States, the company operates in a space where environmental rules and supply constraints can shape demand and pricing. With a market capitalization around $227 million, the shares tend to move more sharply than those of larger sector peers.

Potential Drivers for Further Gains

A few enduring factors support the idea that the stock could work its way back toward $8. The AIM Act, which phases down high-global-warming-potential hydrofluorocarbons, creates structural demand for reclaimed refrigerants. The company’s five-year, roughly $210 million contract with the Defense Logistics Agency adds revenue visibility, while its partnership with Icorium aims to bolster recovery capabilities and lessen dependence on spot prices. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

On the balance sheet, Hudson carries little to no long-term debt, leaving room to pursue growth as the regulatory backdrop evolves. Should refrigerant prices stabilize and margins return closer to historical norms, earnings could improve and help push the share price toward the higher end of analyst expectations.

Headwinds That Could Slow Progress

The counterarguments are straightforward. Recent quarterly results showed revenue of about $78.3 million, up roughly 8% year over year, yet EPS of $0.12 missed expectations as gross margins fell to about 26% from 31% the prior year. Guidance for 2026 points to gross margins in the low-to-mid 20% range, citing soft refrigerant prices, higher transportation costs, and expenses related to an enterprise software rollout. An oversupplied market and uncertain pricing remain the main near-term challenges.

Analyst Views and Price Targets

Consensus price targets for Hudson Technologies generally fall in the mid-to-high $7 range, with individual estimates spanning $7.00 to $9.50. This positions $8 comfortably inside, though toward the upper-middle of, the professional range. Several firms have lowered targets in 2026 amid margin pressure while keeping generally constructive ratings. The overall consensus leans toward “Buy” or “Hold,” balancing long-term regulatory support against shorter-term profitability concerns.

Important Technical Levels to Watch

The stock’s 52-week range of $4.64 to $10.52 provides context. The $4.64–$5.00 zone has served as support in recent months, while $6.00 has acted as near-term resistance on recovery attempts. Above that, $8 marks both a prior supply area and a round-number milestone. For a sustained advance toward $8, the shares would likely need to post higher lows, clear the $6.00 level, and show a shift from the broader downtrend seen over much of the past year.

Using AI Daily Buy/Sell Signals for Additional Insight

Traders tracking whether HDSN can reach $8 may find value in automated market analysis. Tickeron’s AI Daily Buy/Sell Signals apply artificial intelligence to monitor thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and data-driven analysis. These signals can help surface opportunities, monitor positions, and spot shifting trends more efficiently than manual review alone.

Personal Take on Tickeron Tools

When I’m evaluating names like this one, I often turn to Tickeron’s AI Daily Buy/Sell Signals to get a quick, objective read on momentum and trend changes. The platform has helped me cross-check technical setups against broader market signals without having to sift through dozens of charts manually. It’s become a regular part of my workflow for smaller-cap industrials where volatility can mask underlying developments.

Final Assessment

Whether Hudson Technologies can realistically reach $8 hinges largely on a recovery in refrigerant pricing and gross margins. The structural elements—regulatory support, a sizable government contract, and a leading reclamation position—lend credibility to the target, and $8 sits within the established analyst range. Still, the stock trades below key resistance, and until margins stabilize, the route higher is likely to remain uneven. I’m watching refrigerant price trends, quarterly margin progress, and whether the shares can hold decisively above $6.00, as these factors will largely decide if the $8 objective becomes attainable.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: HDSN

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


HDSN's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for HDSN turned positive on September 10, 2026. Looking at past instances where HDSN's MACD turned positive, the stock continued to rise in 35 of 44 cases over the following month. The odds of a continued upward trend are 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 39 of 52 cases where HDSN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.

Following a +1.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where HDSN advanced for three days, in 203 of 275 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

HDSN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HDSN as a result. In 63 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 72%.

HDSN moved below its 50-day moving average on August 18, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for HDSN crossed bearishly below the 50-day moving average on August 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 65%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HDSN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.

The Aroon Indicator for HDSN entered a downward trend on August 31, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.935) is normal, around the industry mean (6.603). P/E Ratio (25.667) is within average values for comparable stocks, (36.348). Projected Growth (PEG Ratio) (0.392) is also within normal values, averaging (2.079). HDSN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (0.917) is also within normal values, averaging (62.734).

The Tickeron Price Growth Rating for this company is 72 (best 1 - 100 worst), indicating slightly worse than average price growth. HDSN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 82 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HDSN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.

The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 11.11B. The market cap for tickers in the group ranges from 47 to 214.92B. LIN holds the highest valuation in this group at 214.92B. The lowest valued company is GTBT at 47.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was -2%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 6%. YMAT experienced the highest price growth at 22%, while ASPI experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was 14%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was -50%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 57
Price Growth Rating: 57
SMR Rating: 78
Profit Risk Rating: 82
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
HDSN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a refrigerant services company

Industry ChemicalsSpecialty

Profile
Details
Industry
Environmental Services
Address
300 Tice Boulevard
Phone
+1 845 735-6000
Employees
281
Web
https://www.hudsontech.com
Interact to see
Advertisement
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.
Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32. The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024.
RAIL shares fell approximately 15% in premarket trading on March 10, 2026, following a steep after-hours reaction to disappointing Q4 2025 earnings results released after the close on March 9. The primary catalyst was a significant revenue miss: Q4 revenue came in at $125.6 million, well below consensus estimates near $144–$160 million, representing an 8.8% year-over-year decline.
ZVRA shares surged approximately +17.86% on March 10, 2026, driven by a blockbuster Q4 and full-year 2025 earnings report released before the market open. Primary catalyst: Q4 2025 EPS of $0.19 crushed the consensus estimate of $0.05 — a 280% beat — while revenue of $34.1 million exceeded forecasts by 21.57%.
LITE surged +14.73% on Monday, March 9, 2026, closing at $640.69 versus a prior close of $558.44 on March 6. The primary catalyst was the landmark $2 billion strategic investment by NVIDIA announced March 2, with the market continuing to price in its full implications following a brief post-announcement pullback.
Shares of BNTX fell approximately 22% on Tuesday, March 10, 2026, following a dual shock of disappointing full-year guidance and a surprise leadership upheaval. The primary catalyst was BioNTech's Q4 2025 earnings report, which included a 2026 revenue outlook of €2.0–€2.3 billion — well below analyst consensus and signaling continued pressure from declining COVID-19 vaccine demand.
CNC shares fell approximately 10% during Tuesday's session, extending a prolonged selloff in the managed care sector. The primary catalyst is intensifying investor concern over federal Medicaid and ACA funding cuts tied to the "One Big Beautiful Bill Act" (OBBBA), which threatens to shrink the government-sponsored insurance pools that Centene depends on for the majority of its revenue.
Technology recently peaked near 35% of the S&P 500 and has slipped over the last year, while Energy plus Materials remain near historically low combined weight at roughly 6%, which suggests the gap is still unusually wide.
Average daily equity purchases by retail investors on S&P 500 down days in 2026 are at the highest level on record, running about 100% above the peak intensity seen during the 2021 meme‑stock boom.
Over the past two weeks, PLTR has climbed from roughly the high‑130s to the mid‑150s, a gain of about 12–14%, with a series of strong up days between March 2 and March 6.
AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.
KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.
NBIS shares surged approximately +10% in premarket trading on March 11, 2026, from a prior close of $96.32. The primary catalyst is the imminent addition of Nebius Group to the Bloomberg 500 (B500) Index, effective prior to the open of trading on Thursday, March 12, 2026.
ORCL shares surged approximately +10.49% in Wednesday's premarket session, trading around $165.07 versus Tuesday's closing price of $149.40. The primary catalyst is Oracle's Q3 FY2026 earnings beat, with adjusted EPS of $1.79 vs. the $1.70 consensus estimate, and revenue of $17.2 billion topping the $16.92 billion forecast.
Shares of AngloGold Ashanti plc (AU) are down approximately 5.00% in early trading on March 11, 2026, falling from a prior close of $108.26 to around $102.85. The primary driver is a renewed pullback in gold prices, which has weighed heavily on gold mining equities across the board.
HMY shares are trading down approximately 13% in early session trading on March 11, 2026, following the release of the company's H1 FY26 interim results. Revenue of R44.4 billion (~US$2.6 billion) missed analyst consensus estimates of R47.56 billion, a significant shortfall that spooked investors.
FICO fell over 9% today, extending a multi‑week downtrend that has already knocked the stock more than 7% lower since its last earnings update. The decline comes despite strong recent financial results, including double‑digit revenue growth, expanding margins, and repeated earnings beats.
RERE fell roughly 10% today, giving back a portion of its strong gains over the past year and month, as traders reacted to fresh earnings and guidance. The company delivered robust Q4 2025 results, with revenue growth near 30% year over year and earnings per share ahead of consensus estimates, underscoring continued operational momentum.
Top hedge funds like Millennium, Citadel, and Bridgewater showed limited direct accumulation of penny stocks in Q4 2025 13F filings, but rotations into biotech, energy, and defense sectors highlight indirect interest in low-priced plays under $5. New entries and increased positions focused on volatile sectors like biotech (e.g., ABCL) and energy (e.g., AMPY), with full exits from overvalued names signaling a hunt for undervalued pennies amid market uncertainty.